[HTML][HTML] Isolation and characterization of a novel autographiviridae phage and its combined effect with tigecycline in controlling multidrug-resistant acinetobacter …

P Wintachai, K Surachat, K Singkhamanan - Viruses, 2022 - mdpi.com
Multidrug-resistant Acinetobacter baumannii (MDR A. baumannii) is one of the ESKAPE
pathogens that restricts available treatment options. MDR A. baumannii is responsible for a …

Isolation and Characterization of a Novel Autographiviridae Phage and Its Combined Effect with Tigecycline in Controlling Multidrug-Resistant Acinetobacter …

P Wintachai, K Surachat, K Singkhamanan - Viruses, 2022 - pubmed.ncbi.nlm.nih.gov
Multidrug-resistant Acinetobacter baumannii (MDR A. baumannii) is one of the ESKAPE
pathogens that restricts available treatment options. MDR A. baumannii is responsible for a …

Isolation and Characterization of a Novel Autographiviridae Phage and Its Combined Effect with Tigecycline in Controlling Multidrug-Resistant Acinetobacter …

P Wintachai, K Surachat… - Viruses (1999 …, 2022 - search.ebscohost.com
Multidrug-resistant Acinetobacter baumannii (MDR A. baumannii) is one of the ESKAPE
pathogens that restricts available treatment options. MDR A. baumannii is responsible for a …

[PDF][PDF] Isolation and Characterization of a Novel Autographiviridae Phage and Its Combined Effect with Tigecycline in Controlling Multidrug-Resistant Acinetobacter …

P Wintachai, K Surachat, K Singkhamanan - 2022 - researchgate.net
Multidrug-resistant Acinetobacter baumannii (MDR A. baumannii) is one of the ESKAPE
pathogens that restricts available treatment options. MDR A. baumannii is responsible for a …

[HTML][HTML] Isolation and Characterization of a Novel Autographiviridae Phage and Its Combined Effect with Tigecycline in Controlling Multidrug-Resistant Acinetobacter …

P Wintachai, K Surachat, K Singkhamanan - Viruses, 2022 - ncbi.nlm.nih.gov
Multidrug-resistant Acinetobacter baumannii (MDR A. baumannii) is one of the ESKAPE
pathogens that restricts available treatment options. MDR A. baumannii is responsible for a …

Isolation and Characterization of a Novel Autographiviridae Phage and Its Combined Effect with Tigecycline in Controlling Multidrug-Resistant Acinetobacter …

P Wintachai, K Surachat, K Singkhamanan - agris.fao.org
Multidrug-resistant Acinetobacter baumannii (MDR A. baumannii) is one of the ESKAPE
pathogens that restricts available treatment options. MDR A. baumannii is responsible for a …

Isolation and Characterization of a Novel Autographiviridae Phage and Its Combined Effect with Tigecycline in Controlling Multidrug-Resistant Acinetobacter …

P Wintachai, K Surachat, K Singkhamanan - Viruses, 2022 - search.proquest.com
Multidrug-resistant Acinetobacter baumannii (MDR A. baumannii) is one of the ESKAPE
pathogens that restricts available treatment options. MDR A. baumannii is responsible for a …

Isolation and Characterization of a Novel Autographiviridae Phage and Its Combined Effect with Tigecycline in Controlling Multidrug-Resistant Acinetobacter …

P Wintachai, K Surachat, K Singkhamanan - Viruses, 2022 - europepmc.org
Multidrug-resistant Acinetobacter baumannii (MDR A. baumannii) is one of the ESKAPE
pathogens that restricts available treatment options. MDR A. baumannii is responsible for a …

Isolation and Characterization of a Novel Autographiviridae Phage and Its Combined Effect with Tigecycline in Controlling Multidrug-Resistant Acinetobacter …

P Wintachai, K Surachat, K Singkhamanan - Viruses, 2022 - europepmc.org
Multidrug-resistant Acinetobacter baumannii (MDR A. baumannii) is one of the ESKAPE
pathogens that restricts available treatment options. MDR A. baumannii is responsible for a …

[引用][C] Isolation and Characterization of a Novel Autographiviridae Phage and Its Combined Effect with Tigecycline in Controlling Multidrug-Resistant Acinetobacter …

P Wintachai, K Surachat, K Singkhamanan - 2022